Serum zinc, copper and ferritin levels in transfusion dependent thalassemia patients with iron chelator therapy

Background: Transfusion dependent thalassemia (TDT) patients require regular blood transfusion and iron chelator therapy to maintain their life. Iron chelator may alter serum zinc and copper level in TDT patients